← Back to Search

Behavioral Intervention

Yoga for Cardiovascular Disease (SLYM II Trial)

Q: Is the target population of this experiment limited to those aged 50 and up?

In order to participate in this clinical trial, patients must meet the age criteria of 18-80. There are 47 studies for minors and 902 specifically designed for seniors over 65.

Q: What criteria would make an individual the most suitable candidate for this trial?

This clinical trial seeks 120 adults between the ages of 18 and 80 who have coronary artery disease to join. Eligible participants must also meet a range of criteria, such as having undergone PCI at Mount Sinai Hospital (<a href="https://www.withpower.com/clinical-trials/new-york">New york</a>), or suffering from one CVD risk factor along with metabolic abnormalities like elevated fasting plasma glucose levels. Furthermore, those diagnosed with metabolic syndrome are welcome to apply so long as they abide by conditions regarding waist circumference measurements, triglyceride/HDL <a href="https://www.withpower.com/clinical-trials/cholesterol">cholesterol</a> concentrations, blood pressure readings and more. In addition <a href="https://www.withpower.com/clinical-trials/all">all</a> candidates need to be able to consent willingly and comply with study requirements for participation.

Q: What is the cap on participants for this experiment?

Affirmative. Per the information on clinicaltrials.gov, this medical experiment is currently open to participants and was initially advertised on January 24th 2022. The most recent update occurred May 4th 2022 and they are searching for 120 individuals from a single location.

Q: Are there any enrollment opportunities for this clinical investigation?

Affirmative. According to clinicaltrials.gov, this medical investigation is open for recruitment and began on January 24th 2022 with its latest update coming in May 4th 2022. 120 individuals are required from a single location.

N/A

Recruiting

Led By Annapoorna Kini, MD

Research Sponsored by Icahn School of Medicine at Mount Sinai

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Subjects eligible for the study are 18-80 year old adults

Subjects diagnosed with metabolic syndrome, which is defined as three or more of the following conditions: (1) Central or abdominal obesity (waist circumference > 40 inches for men and > 35 inches for women); (2) High triglycerides (≥150 mg/dL or triglycerides treatment); (3) Low HDL cholesterol (<40 mg/dL for men and <50 mg/dL for women) or low HDL-C treatment; (4) High blood pressure (≥130/85 mmHg) or antihypertensive medications; (5) High fasting glucose (≥100 mg/dL) or type 2 diabetes mellitus

Timeline

Screening 3 weeks

Treatment Varies

Follow Up end of study, at 22 months

Awards & highlights

SLYM II Trial Summary

This trial will test whether a 16-week yoga program can improve micro RNA expression and reduce cardiovascular disease risk factors.

Who is the study for?

Adults aged 18-80 with metabolic syndrome and cardiovascular disease who have undergone certain heart procedures or have risk factors like high blood pressure can join. They must be able to do yoga and follow the study plan. People with severe heart failure, arrhythmias, implants, autoimmune diseases, recent transplants or pregnancy, severe lung disease, liver issues or heavy alcohol use cannot participate.Check my eligibility

What is being tested?

The trial is testing if a 16-week chair yoga program can change micro RNA expression linked to heart disease and improve related health markers in patients with cardiovascular conditions.See study design

What are the potential side effects?

Chair yoga is generally safe but may include muscle soreness or strain. Since it's gentle exercise designed for those with limited mobility, serious side effects are not common.

SLYM II Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 80 years old.

Select...

I have been diagnosed with metabolic syndrome, having at least three of the specified conditions.

SLYM II Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ end of study, at 22 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~end of study, at 22 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study, at 22 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

micro RNA expression

Secondary outcome measures

Blood pressure

Body weight

Waist circumference

SLYM II Trial Design

2Treatment groups

Active Control

Group I: YogaActive Control1 Intervention

Patients randomized to Yoga arm will practice chair yoga for 30 minutes at least three days a week for 16 weeks

Group II: Standard of CareActive Control1 Intervention

Control group patients will follow standard of care (SOC) treatment.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor

861 Previous Clinical Trials

525,156 Total Patients Enrolled

23 Trials studying Coronary Artery Disease

28,900 Patients Enrolled for Coronary Artery Disease

Annapoorna Kini, MDPrincipal InvestigatorMOUNT SINAI HOSPITAL

6 Previous Clinical Trials

5,235 Total Patients Enrolled

5 Trials studying Coronary Artery Disease

540 Patients Enrolled for Coronary Artery Disease

Media Library

Chair Yoga (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05250310 — N/A

Coronary Artery Disease Research Study Groups: Yoga, Standard of Care

Coronary Artery Disease Clinical Trial 2023: Chair Yoga Highlights & Side Effects. Trial Name: NCT05250310 — N/A

Chair Yoga (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05250310 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the target population of this experiment limited to those aged 50 and up?

"In order to participate in this clinical trial, patients must meet the age criteria of 18-80. There are 47 studies for minors and 902 specifically designed for seniors over 65."

Answered by AI

What criteria would make an individual the most suitable candidate for this trial?

"This clinical trial seeks 120 adults between the ages of 18 and 80 who have coronary artery disease to join. Eligible participants must also meet a range of criteria, such as having undergone PCI at Mount Sinai Hospital (New york), or suffering from one CVD risk factor along with metabolic abnormalities like elevated fasting plasma glucose levels. Furthermore, those diagnosed with metabolic syndrome are welcome to apply so long as they abide by conditions regarding waist circumference measurements, triglyceride/HDL cholesterol concentrations, blood pressure readings and more. In addition all candidates need to be able to consent willingly and comply with study requirements for participation."

Answered by AI

What is the cap on participants for this experiment?

"Affirmative. Per the information on clinicaltrials.gov, this medical experiment is currently open to participants and was initially advertised on January 24th 2022. The most recent update occurred May 4th 2022 and they are searching for 120 individuals from a single location."

Answered by AI

Are there any enrollment opportunities for this clinical investigation?

"Affirmative. According to clinicaltrials.gov, this medical investigation is open for recruitment and began on January 24th 2022 with its latest update coming in May 4th 2022. 120 individuals are required from a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Effect of Structured Lifestyle Modification and Yoga Practice on Metabolic Processes Associated With Cardiovascular Disease

Annapoorna Kini 2022. "The Effect of Structured Lifestyle Modification and Yoga Practice on Metabolic Processes Associated With Cardiovascular Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05250310.

All > Coronary Artery Disease